Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease
Status:
Completed
Trial end date:
2006-07-21
Target enrollment:
Participant gender:
Summary
Human mesenchymal stem cells (MSCs), derived from healthy adult volunteer human donors, can
be obtained from bone marrow donation and cultured in the laboratory. MSCs have shown the
ability to find injured tissue, reduce and control inflammation, and assist in tissue repair.
Prochymal™ MSCs will be infused into patients with moderate-to-severe Crohn's disease.
Infusions will occur on two separate days, 7-10 days apart. Patients will be monitored for
reduced Crohn's disease symptoms.